Fundraising Fox

Markus Enzelberger

Investor

Partner at Versant Ventures

Munich, Germany

Writes $100K – $5M checks · typically $1.5M

About

Markus is a Versant partner in Basel who helps launch new companies from the firm's Ridgeline Discovery Engine. A drug discovery and protein engineering expert, he previously served as CSO and management board member of MorphoSys, which he joined in 2002, and holds a Ph.D. from the Technical University of Stuttgart.

Experience

  1. Versant VenturesPartnercurrent2020 — presentBasel, Basel, Switzerland
  2. Versant VenturesEntrepreneur in Residence2020Basel, Basel, Switzerland
  3. Granite BioBoard Membercurrent2021 — presentBasel, Switzerland
  4. Serac BiosciencesBoard Membercurrent2023 — present
  5. Red Ridge BioBoard Membercurrent2024 — presentBasel, Switzerland
  6. Abdera TherapeuticsBoard Observercurrent2021 — present
  7. Ridgeline DiscoveryBoard Membercurrent2020 — present
  8. Cimeio TherapeuticsBoard Membercurrent2020 — present
  9. SHS CapitalSenior Advisorcurrent2017 — present
  10. T-knifeBoard Observercurrent2020 — present
  11. SixPeaks BioBoard Member2023 — 2025Basel, Switzerland
  12. Matterhorn BiosciencesBoard Member2022 — 2025Basel, Switzerland
  13. Develco Pharma Schweiz AGAufsichtsratsmitglied2022 — 2024Basel, Switzerland
  14. Vertical BioscienceBoard Member2020 — 2023Basel
  15. Vector BioPharmaBoard Member2020 — 2023
  16. GNA Biosolutions GmbHAufsichtsratsmitglied2018 — 2021Martinsried
  17. MorphoSys AGCSO2017 — 2020Greater Munich Metropolitan Area
  18. MorphoSys AGinterim-CSO2017Greater Munich Metropolitan Area
  19. MorphoSys AGSenior Vice President2002 — 2017Greater Munich Metropolitan Area
  20. MorphoSys AGVice President2002 — 2012

Education

  1. CaltechPostdoc, Applied Physics1999 — 2002
  2. University of StuttgartPromotion, Chemie1990 — 1999

Skills & more

Pharmaforschung4Biowissenschaften10Biotechnologie13Pharmaindustrie14Molekularbiologie10Technologietransfer7Biochemie4Biopharmazeutika1Immunologie2Arzneimittelentwicklung7BiokatalyseAntikörper2
+8 moreProteinchemieForschung und EntwicklungTechnology TransferClinical DevelopmentOnkologieBiopharmaceuticalsBiotechnologyTechnology

From Markus's professional profile.

Same school

Shared employers

Colleagues at Versant Ventures